Arch Personal Care has introduced two new globally approved patent pending systems, Mikrokill PCC and Mikrokill COS and re-introduced two existing products, Biovert and Cosmocil CQ, which recently became part of the company’s new preservation product portfolio when Arch Chemicals acquired Avecia in 2004. According to Eva-Maria Harthaus, senior technical marketing specialist, the Paraben cancer controversy has alarmed many personal care companies and has opened the doors to consideration of alte...